Article
Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently.
Gut - 1 May 2015
Beilfuss Anja, Sowa Jan-Peter, Sydor Svenja, Beste Mechthild, Bechmann Lars P, Schlattjan Martin, Syn Wing-Kin, Wedemeyer Inga, Mathé Zoltan, Jochum Christoph, Gerken Guido, Gieseler Robert K, Canbay Ali
Abstract excerpt
OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is closely linked to obesity and constitutes part of the metabolic syndrome, which have been associated with low serum vitamin D (VD). Due to known crosstalk between VD and transforming growth factor (TGF)-β signalling, VD has been proposed as an antifibrotic treatment. DESIGN: We evaluated the association between VD, the vitamin D receptor (VDR) and liver...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
